CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $264,622 | -19.1% | 14,227 | -44.2% | 0.08% | -42.1% |
| Q3 2022 | $327,000 | +48.0% | 25,480 | -19.3% | 0.13% | +15.7% |
| Q2 2022 | $221,000 | -37.0% | 31,571 | -25.4% | 0.12% | -1.7% |
| Q1 2022 | $351,000 | -4.9% | 42,293 | -22.6% | 0.12% | +34.5% |
| Q4 2021 | $369,000 | +27.7% | 54,618 | 0.0% | 0.09% | +26.1% |
| Q3 2021 | $289,000 | -8.0% | 54,618 | 0.0% | 0.07% | +97.1% |
| Q2 2021 | $314,000 | – | 54,618 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |